Mylan Laboratories

Mylan Corporation

A single standard for drugs around the world: Mylan Corporation

Mylan pharmaceutical company was founded in 1961 in the US state of West Virginia. Initially, the company started out as a distributor, buying finished products and selling them to doctors and pharmacies. 4 years later, in 1965, the company launched its vitamins and empty gelatin capsules. Then, in 1966, Mylan received approval to release penicillin G. In addition, the company has constantly expanded its product line to include other antibiotics, analgesics, steroids and antihistamines.

Today, the pharmaceutical company Mylan is one of the leading companies with more than 1400 different medicines and products in more than 150 countries. The company has taken the leading positions due to a wide range of drugs, convenient delivery, huge scale of production and high quality products.

Pharmaceutical company Mylan also manufactures API antiretroviral drugs, which are used to treat the deadly AIDS virus, and supplies pharmaceutical ingredients for generic antiretroviral drugs.

Mylan Laboratories SAS

Since the early 1980s, Mylan has been acquiring small drug companies. The company also acquired research laboratories where unique formulations of vital drugs were developed. A wave of mergers touched the Indian company Matrix Laboratories, which specialized in the production and sale of substances used in the manufacture of pharmaceuticals. Thus, Mylan gained access to the Indian drug market. Matrix Laboratories soon morphed into Mylan Laboratories with offices in several countries. Now the company operates under this brand in France and India. The French branch is called Mylan Laboratories SAS, the Indian one is Mylan Pharmaceuticals Private Limited. These divisions specialize in the production of generic drugs. So, under the license transferred by the World Health Organization from the American company Gilead Sciences, Mylan Laboratories SAS began producing antiviral drugs containing:

· Sofosbuvir;

Daclatasvir;

Velpatasvir;

· Ledipasvir.

As the exclusive distributor for Gilead, Mylan Laboratories SAS markets drugs under the following brand names:

Myhep LVIR

· Myhep;

Mydacla et al.

The drugs are prescribed for patients with hepatitis C of different genotypes.

Mylan Laboratories SAS Benefits

Employees of this organization are constantly developing the latest medicines, with the help of which it is possible to treat not only viral, but also other serious diseases. Among the advantages of Mylan Laboratories SAS are:

1. Excellent quality pharmaceuticals.

2. Compliance with the functionality of generics.

3. Relatively low cost of drugs.

The company's products are accompanied by positive reviews from patients and doctors from all over the world.